fosinopril sodium and hydrochlorothiazide

Generic: fosinopril sodium and hydrochlorothiazide

Labeler: cipla usa inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name fosinopril sodium and hydrochlorothiazide
Generic Name fosinopril sodium and hydrochlorothiazide
Labeler cipla usa inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

fosinopril sodium 20 mg/1, hydrochlorothiazide 12.5 mg/1

Manufacturer
CIPLA USA INC.

Identifiers & Regulatory

Product NDC 69097-973
Product ID 69097-973_25e66ad5-947a-4262-a996-a9695601d301
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA090228
Listing Expiration 2026-12-31
Marketing Start 2020-07-24

Pharmacologic Class

Established (EPC)
thiazide diuretic [epc]
Chemical Structure
thiazides [cs]
Physiologic Effect
increased diuresis [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 69097973
Hyphenated Format 69097-973

Supplemental Identifiers

RxCUI
857166 857174
UPC
0369097973070 0369097972073
UNII
0J48LPH2TH NW2RTH6T2N
NUI
N0000175359 N0000175419 M0471776

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name fosinopril sodium and hydrochlorothiazide (source: ndc)
Generic Name fosinopril sodium and hydrochlorothiazide (source: ndc)
Application Number ANDA090228 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 20 mg/1
  • 12.5 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (69097-973-07)
source: ndc

Packages (1)

Ingredients (2)

fosinopril sodium (20 mg/1) hydrochlorothiazide (12.5 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "25e66ad5-947a-4262-a996-a9695601d301", "openfda": {"nui": ["N0000175359", "N0000175419", "M0471776"], "upc": ["0369097973070", "0369097972073"], "unii": ["0J48LPH2TH", "NW2RTH6T2N"], "rxcui": ["857166", "857174"], "spl_set_id": ["4e1ed7da-029e-48d6-a5e4-fc7ac11192fb"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "manufacturer_name": ["CIPLA USA INC."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (69097-973-07)", "package_ndc": "69097-973-07", "marketing_start_date": "20200724"}], "brand_name": "Fosinopril Sodium and Hydrochlorothiazide", "product_id": "69097-973_25e66ad5-947a-4262-a996-a9695601d301", "dosage_form": "TABLET", "pharm_class": ["Angiotensin Converting Enzyme Inhibitor [EPC]", "Angiotensin-converting Enzyme Inhibitors [MoA]", "Increased Diuresis [PE]", "Thiazide Diuretic [EPC]", "Thiazides [CS]"], "product_ndc": "69097-973", "generic_name": "Fosinopril Sodium and Hydrochlorothiazide", "labeler_name": "CIPLA USA INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Fosinopril Sodium and Hydrochlorothiazide", "active_ingredients": [{"name": "FOSINOPRIL SODIUM", "strength": "20 mg/1"}, {"name": "HYDROCHLOROTHIAZIDE", "strength": "12.5 mg/1"}], "application_number": "ANDA090228", "marketing_category": "ANDA", "marketing_start_date": "20200724", "listing_expiration_date": "20261231"}